Imatinib Tablet is a breakthrough targeted therapy used in the treatment of chronic myeloid leukemia (CML) and certain gastrointestinal stromal tumors (GIST). Imatinib Tablet works by blocking abnormal proteins that drive cancer cell growth, helping to control the disease effectively.
With consistent use under specialist supervision, it supports long-term disease management and improved patient outcomes.
